Skip to main content

Pregnancy: Pregestational and Gestational Management

  • Chapter
  • First Online:
The Diabetes Textbook

Abstract

Gestational diabetes (GD) is a complication of pregnancy with an incidence of up to 16%, characterized by alteration in carbohydrate metabolism. It is a condition that favors greater risk of developing complications such as congenital malformations, stillbirth, preeclampsia, fetal macrosomia, polyhydramnios, greater index of cesareans, and hemorrhagic complications that it brings. Its etiology is multifactorial, including genetic determinants such as ethnicity; lifestyle, where sedentary lifestyle plays the most important role; easy access to high-caloric foods; and the socioeconomic level, where the lower strata have the highest risk. Diagnosis is easy to perform from the identification of women of reproductive age with risk factors and from the first prenatal visit, by measuring blood glucose. General measures such as lifestyle and diet modification of the pregnant patient are the beginning of treatment. In the case of not reaching control of glucose levels, oral hypoglycemic drug and insulin are the basis of treatment with the object of maximum reduction of complications for both mother and neonate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Liat S, Cabrero L, Hod M, Yogev Y. Obesity in obstetrics. Best Pract Res Clin Obstet and Gynaecol. 2015;29:79–90.

    Article  Google Scholar 

  2. Aviram A, Hod M, Yogev Y. Maternal obesity: implications for pregnancy outcome and long-term risks—a link to maternal nutrition. Int J Gynecol Obstet. 2011;115(Suppl 1):S6–S10.

    Article  Google Scholar 

  3. Albrecht SS, Barquera S, Popkin BM. Exploring secular changes in the association between BMI and waist circumference in Mexican-Origin and White women: a comparison of Mexico and the United States. Am J of Hum Biol. 2014;26:627–34.

    Article  Google Scholar 

  4. ACOG. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol. 2013;122(2 Pt 1):406–16.

    Google Scholar 

  5. McCance DR. Diabetes in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015;29:685–99.

    Article  Google Scholar 

  6. Lawrence JM. Women with diabetes in pregnancy: different perceptions and expectations. Best Pract Res Clin Obstet Gynaecol. 2011;25:15–24.

    Article  Google Scholar 

  7. Crume TL, Ogden L, West NA, et al. Association of exposure to diabetes in utero with adiposity and fat distribution in a multiethnic population of youth: The Exploring Perinatal Outcomes among Children (EPOCH) Study. Diabetologia. 2011;54:87–92.

    Article  CAS  Google Scholar 

  8. Hadar E, Ashwal E, Hod M. The preconceptional period as an opportunity for prediction and prevention of non-communicable disease. Best Pract Res Clin Obstet Gynaecol. 2015;29:54–62.

    Article  Google Scholar 

  9. American Diabetes Association. Classification and diagnosis of diabetes. Sec. 2. In standards of medical care in diabetes 2016. Diabetes Care. 2016;39(Suppl. 1):S13–22.

    Google Scholar 

  10. Sacks DA, Metzger BE. Classification of diabetes in pregnancy. Time to reassess the alphabet. Obstet Gynecol. 2013;121(2):345–8.

    Article  Google Scholar 

  11. The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.

    Article  Google Scholar 

  12. Ogunyemi DA, Fong A, Rad S, Fong S, Kjos SL. Attitudes and practices of health care providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Pregnancy Study Group (IADPSG). Diabet Med. 2011;28(8):976–86.

    Article  CAS  Google Scholar 

  13. Wendland EM, Torloni MR, Falavigna M, et al. Gestational diabetes and pregnancy outcomes – a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth. 2012;12:23. https://doi.org/10.1186/1471-2393-12-23.

    Article  PubMed  PubMed Central  Google Scholar 

  14. McIntyre HD, Metzger BE, Coustan DR, et al. Counterpoint: establishing consensus in the diagnosis of GDM following the HAPO study. Curr Diab Rep. 2014;14:497.

    Article  Google Scholar 

  15. American Diabetes Association. Management of diabetes in pregnancy. Sec. 12. In standards of medical care in diabetes. Diabetes Care. 2016;39(Suppl 1):S94–8.

    Google Scholar 

  16. Buchanan TA. Intermediary metabolism durin pregnancy: implication for diabtes mellitus. En: Le Roith D, Olefsky JM, Tyalor SI. Diabetes mellitus: a fundamental and clinical text (3). Philadelphia: Wolters Kluwer Health; 2003. Pro Quest Library. pp. 1237–50.

    Google Scholar 

  17. Buchanan TA. Effects of maternal diabetes mellitus on intrauterine development. En: Le Roith D, Olefsky JM, Tyalor SI. Diabetes mellitus: a fundamental and clinical text (3). Philadelphia: Wolters Kluwer Health; 2003. Pro Qeust ebrary. pp. 1251–64.

    Google Scholar 

  18. Tessier DR, Ferraro ZM, Gruslin A. Role of leptin in pregnancy: consequences of maternal obesity. Placenta. 2013;34:205–11.

    Article  CAS  Google Scholar 

  19. Guía de Práctica Clínica. Diagnóstico y Tratamiento de la Diabetes en el Embarazo. México: Secretaria de Salud; 2009.

    Google Scholar 

  20. Berggren EK, Boggess KA. Oral agents for the management of gestational diabetes. Clinical Obstet GynecolLippincott Williams and Wilkins. 2013;56(4):827–36.

    Article  Google Scholar 

  21. Spaulonci CP, Bernardes LS, Trindade TC, et al. Randomized trial of metformin vs insulin in the management of gestational diabetes. Am J Obstet Gynecol. 2013;209:34. e1–7.

    Article  CAS  Google Scholar 

  22. Zhao LP, Sheng XY, Zhou S, Yang T, Ma LY, Zhou Y, Cui YM. Metformin versus insulin for gestational diabetes mellitus: a meta-analysis. Br J Clin Pharmacol. 2015;80(5):1224–34.

    Article  CAS  Google Scholar 

  23. Singh AK, Singh R. Metformin in gestational diabetes: an emerging contender. Indian J Endocrinol Metab. 2015;19(2):236–44.

    Article  Google Scholar 

  24. Korkmazer E, Solak N, Tokgöz VY. Gestational diabetes: screening, management, timing of delivery. Curr Obstet Gynecol Rep. 2015;4:132–8.

    Article  Google Scholar 

  25. Benhalima K, Devlieger R, Van Assche A. Screening and management of gestational diabetes. Best Pract Res Clin Obstet Gynaecol. 2015;29:339–49.

    Article  Google Scholar 

  26. Garrison EA, Jagasia S. Inpatient management of women with gestational and pregestational diabetes in pregnancy. Curr Diab Rep. 2014;14:457.

    Article  Google Scholar 

  27. Theodoraki A, Baldeweg SE. Symposium on diabetes. Gestational diabetes mellitus. Br J Hosp Med. 2008;69(10):562–7.

    Article  CAS  Google Scholar 

  28. Gunderson EP. Breastfeeding after gestational diabetes pregnancy. Diabetes Care ProQuest. 2007;30(S2):S161–8.

    Article  Google Scholar 

  29. Trout KK, Averbuch T, Barowski M. Promoting breastfeeding among obese women and women with gestational diabetes mellitus. Curr Diab Rep. 2011;11(7):7–12.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Glossary

ACOG

The American College of Obstetricians and Gynecologists.

ADA

The American Diabetes Association.

BMI

Is the result of dividing the weight of a person in kilograms by the square of his height in meters.

Congenital malformations

are anatomic alterations that occur in the intrauterine stage and may be alterations in organs, extremities or systems, due to environmental, genetic factors, deficiencies in nutrient capture, or consumption of noxious substances.

ENSANUT 2012

National Health and Nutrition Survey 2012 (Mexico).

FDA

The Food and Drug Administration.

Fetal macrosomia

Traditionally, fetal macrosomia has been defined as arbitrary weight at birth, such as 4000, 4100, 4500, or 4536 grams. It is currently defined as a fetus that is large for gestational age (> 90 percentile).

GD

Gestational diabetes, which is defined as alteration in carbohydrate metabolism diagnosed for the first time in the second or third trimester of gestation.

HAPO Study

Hyperglycemia and Adverse Pregnancy Outcomes study.

IADPSG

The International Association of Diabetes and Pregnancy Study Groups.

Insulin

From the Latin “isla.” It is a polypeptide hormone formed by 51 amino acids, produced and secreted by the beta cells of the Islets of Langerhans of the pancreas. Discovered by Frederick Grant Banting, Charles Best, James Collip, and J.J.R. Macleod of the University of Toronto, Canada in 1921.

NIH

National Institutes of Health.

Obesity

Obesity and overweight are defined as abnormal or excessive accumulation of fat that may prejudice health. A simple way to measure obesity is the body mass index (BMI), which is the weight of a person divided by height in meters squared. A person with BMI equal or above 30 is considered obese and with a BMI equal or greater than 25 is considered overweight.

Oral hypoglycemic drugs

Antidiabetic drugs which are classified as sulfonylureas, biguanides, alpha-glucosidase inhibitors, meglitinides (repaglinide, nateglinide) and thiazolidinediones.

Perinatal mortality

is the fetus and newborn risk of dying as a consequence of the reproductive process.

Premature birth

According to WHO, birth that occurs after week 20 and before 37 complete weeks.

T1D

Type 1 diabetes, which is secondary to the destruction of the beta cells of the pancrease, and in general leads to absolute insulin deficiency.

T2D

Type 2 diabetes, which is due to a progressive loss of insulin secretion.

WHO

World Health Organization.

Women of reproductive age

Women between 15 and 44 years.

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

García-Argueta, M.I., González-Espejel, M. (2019). Pregnancy: Pregestational and Gestational Management. In: Rodriguez-Saldana, J. (eds) The Diabetes Textbook. Springer, Cham. https://doi.org/10.1007/978-3-030-11815-0_61

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-11815-0_61

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-11814-3

  • Online ISBN: 978-3-030-11815-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics